eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 15/08/2011
PIL Kaletra 100mg/25mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to dosage and administration
  • Extra statutory information
Updated on 16/11/2010 and displayed until 15/08/2011
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
  • Change to side-effects
Updated on 04/06/2010 and displayed until 16/11/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 06/01/2010 and displayed until 04/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to MA holder contact details
Updated on 24/09/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/09/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 30/05/2008 and displayed until 25/09/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ritonavir
   lopinavir